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Abstract 
BACKGROUND: Schizophrenia is a psychopathological syndrome clinic involving cognition, emotion, perception 
and other aspects from the individual which interferences. This interference is normally started before age 25, and 
it can affect all social classes. 
AIM: To find out the difference in total positive and negative syndrome scale (PANSS) scores in schizophrenia 
between Bataknese and Javanese who have received treatment with risperidone. 
METHODS: This study is a prospective study. This study used numeric comparative analytic two unpaired groups 
to observe the differences of PANSS score of the man with schizophrenia between Bataknese and Javanese who 
had received risperidone treatment. 
RESULTS: Our study found that the average score of PANSS for Bataknese was 49.76 ± 12.65 and Javanese 
was 42.43 ± 9.05. 
CONCLUSION: There was a difference score of PANSS for the man with schizophrenia between Bataknese and 
Javanese who had received risperidone treatment for 6 weeks (p = 0.037). 
 
 
 
 
 
Introduction 
 
Schizophrenia is a disturbing clinical 
syndrome of psychopathology that involves cognition, 
emotions, perceptions, and other aspects of 
behaviour. This disorder usually starts before the age 
of 25 and can attack people from various social 
groups [1]. According to Burroughs, race and ethnicity 
have different responses to treatment. The differences 
of response in race and ethnicity to the treatment are 
influenced by several factors including biological 
factors (age, gender, genetics, illness), cultural factors 
(attitudes, beliefs, family influences), and 
environmental factors (climate, parasites, pollutants, 
smoking, alcohol, medicines) [2]. 
Clinical studies and multicentre trials carried 
out by Buckley in Cleveland conclude that risperidone 
is an antipsychotic that effectively improves positive 
and negative symptoms in schizophrenia globally. The 
study compared risperidone and conventional 
antipsychotics (chlorpromazine) at the mean ± SD 
dose of risperidone at 6.8 ± 2.0 mg and equivalent 
dose of chlorpromazine at 1.295 ± 789 mg to improve 
positive and negative symptoms in schizophrenia [3].
 
Genetics has been known to affect the 
pharmacokinetics and pharmacodynamics of 
antipsychotic drugs. This is based on the time 
separation in the evolutionary trends in Africa. For 
example, genetics in Orientals and Caucasians are 
related to the cytochrome P450 enzymes (CYP 450), 
which have a relationship in the metabolism of 
psychotropic drugs in humans. 
Recent studies on the pharmacokinetics and 
pharmacodynamics of antipsychotic drugs and 
sociocultural factors that influence the response of 
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antipsychotic drugs consistently provide racial 
differences in response to antipsychotic drugs [4]. 
Ethnicity also plays a role in responding to risperidone 
treatment among children and adolescents with the 
schizophrenic disorder [5]. In an experimental study 
by Sianturi [6] in Indonesia, there was a difference in 
the effectiveness of risperidone and haloperidol on the 
positive symptoms of schizophrenic patients in the 
Positive and Negative Syndrome Scale (PANSS) at 
the fourth week. The results showed that the mean 
difference of the PANSS positive scores for the 
risperidone therapy group was 13.1 (SD ± 3.4) 
whereas the mean difference of the PANSS positive 
scores for the haloperidol therapy group was 10.4 (SD 
± 1.9), P = 0.005 (P < 0.05). There was also a 
difference in the PANSS positive delta scores based 
on the intervention groups [6]. Furthermore, a pilot 
study conducted by Frackiewicz et al., [7] found that 
there was a significant difference in the PANSS 
scores between 10 Hispanic schizophrenic in-patients 
and 8 non-Hispanic schizophrenic in-patients who 
received risperidone (p < 0.02). 
Men with schizophrenia usually experience a 
much earlier age onset. They tend to have primary 
negative symptoms associated with the occurrence of 
chronicity which is a large clinical case [8]. 
Schizophrenia is defined as a disorder that lasts for 
six months or more, in which the person has the 
notion, hallucinations, irregular speech, catatonic 
behaviour, or negative symptoms for at least one 
month [9]. Recent studies estimate that 
socioeconomic status might influence health risk 
factors of schizophrenic people to obesity and 
diabetes because lower middle class tend to consume 
excess calories [10]. The PANSS has become a 
standard tool for assessing clinical outcomes in the 
treatment studies of schizophrenia and other 
psychotic disorders and has been proven to be easily 
administered, reliable, and sensitive to changes with 
treatment. The PANSS scores of in-patients rarely 
exceed 80-150 [11]. 
Based on the information obtained from the 
first century AD, the Bataknese tribe originated from 
Greece and Chinese [12]. Indonesia has various 
ethnic groups, and the distribution of the ethnic groups 
is Sundanese with 36.7 million people (15.5%), 
Bataknese with 8.5 million people (3.6%), and other 
ethnic groups from Sulawesi with 7.6 million people 
(3.2%), and others [13]. The Bataknese people are 
known for their openness, spontaneity, and 
aggressiveness both physically and verbally. Previous 
research found that Bataknese people often choose to 
express their anger when they are angry while 
Javanese people tend to hide their anger [14]. Thus, 
Bataknese people mostly have low emotional 
regulation whereas Javanese people have polite 
behaviour in their speech and self-presentation by 
showing respect for others [15], [16]. Risperidone is 
effective for various psychopathology of schizophrenia 
and will be more effective than the First-Generation 
Antipsychotics (FGA). 
Risperidone has been widely used and 
becomes the highest number of antipsychotics in the 
world. Risperidone has a high affinity for dopamine 2 
(D2) and serotonin 2A (5-HT2A) receptors [17]. 
Differences between ethnic groups in drug metabolic 
enzymes and transporters have the potential to cause 
variability in the dose choice [18]. Allele gene 
polymorphisms that highly depend on ethnicity have a 
major role in the functions of 2D6, 2C19, 2C9, 2B6, 
3A5, and 2A6 CYPs and lead to different 
pharmacogenetics phenotypes [19].  
Bakare stated that genetics influence the 
pharmacokinetics and pharmacodynamics of 
antipsychotic drugs, but Patel reported that there were 
significant CBCL differences between African-
American, Hispanic, but not Caucasian races. Also, 
Frackiewicz stated that racial factors affect the 
improvement of PANSS symptoms. However, there 
have been no previous studies in Indonesia that 
examined the relationship between ethnicity and 
risperidone effectiveness in men with schizophrenia. 
Therefore, the researchers were interested in 
conducting this research. 
The present study was the first study 
conducted in Indonesia, especially in North Sumatra, 
which examined PANSS total score differences in 
men with schizophrenia between Bataknese and 
Javanese ethnic groups. To find out the sample size, 
therefore, a preliminary study was carried out from 
July to September 2017 by recruiting 20 subjects with 
10 Bataknese and Javanese, respectively. 
 
 
Methods  
 
The present study was an observational study 
through a prospective cohort approach. This study 
was an unpaired numerical comparative analytical 
study of two groups to determine the difference in the 
PANSS total scores between Bataknese and 
Javanese men with schizophrenia who had received 6 
mg of risperidone for 6 weeks. Subjects in this study 
were determined by consecutive sampling, which is a 
non-probability sampling type. The inclusion criteria in 
this study were male patients who had been 
diagnosed with schizophrenia at the Inpatient 
Installation in Prof. Moh. Ildrem Mental Hospital 
Medan North Sumatra. The patients with age 15-40 
years received a fixed dose of 6 mg of risperidone per 
day and had the PANSS total score of 80-120. Also, 
the subjects had an inappropriate affect and dysphoric 
mood, cooperative (willing to be the research subject), 
normal body mass index, no history of liver disease 
and had a good liver function, had insight I or II when 
patients received 6 mg of risperidone per day. The 
exclusion criteria were having a history of general 
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medical illness and the use of prohibited substances 
except for nicotine and caffeine, having a family 
history of schizophrenia, and having a disease and 
history of kidney disorders. 
The calculation of the sample size giving the 
highest number was 21 subjects for the Javanese 
ethnic group and 21 subjects for the Bataknese ethnic 
group. Data collection was preceded by finding 
patients from Bataknese and Javanese ethnicity who 
were diagnosed with schizophrenia in Prof. Ildrem 
Mental Hospital and received a fixed-dose at 6 mg of 
risperidone (in the first week of treatment). Structured 
interviews using MINI ICD-10 was performed to find 
people with schizophrenia determined by diagnostic 
guidelines based on PPDGJI-III. Screening using 
inclusion and exclusion criteria was done to determine 
the research subjects. In the interviews, several 
information was also collected from the patients 
including the age of the first attack, duration of attack, 
number of attacks, insight, education level, 
socioeconomic level, personality of the patients before 
diagnosed with schizophrenia, family history, and 
history of liver disease and liver function of patients 
from laboratory tests. Men with schizophrenia from 
Bataknese and Javanese ethnicity who fulfilled the 
inclusion criteria filled out written approval after getting 
detailed and clear explanations to participate in the 
study until the number of subjects in each Javanese 
and Bataknese group was 21 patients. Then, the 
PANSS total score of both Bataknese and Javanese 
patients who fulfilled the inclusion criteria and had 
received 6 mg of risperidone (first week of treatment) 
was measured. The patients were observed until the 
sixth week. After the sixth week of treatment, the 
PANSS total score was measured again. The PANSS 
total scores of Bataknese and Javanese male patients 
with schizophrenia in the sixth week were analysed to 
see if there were differences between the Bataknese 
and Javanese subjects. The research results were 
reported and presented in a table. Test analysis was 
performed on the PANSS total scores of the 
Bataknese and Javanese subjects. Data normality 
was tested using the Shapiro-Wilk test because the 
number of samples was 21 subjects for each 
Bataknese and Javanese group (less 50). The 
PANSS total score of the Bataknese and Javanese 
subjects after receiving 6 mg of risperidone for 6 
weeks was normally distributed so that the analysis 
was continued with an unpaired t-test. The PANSS 
total scores of the Bataknese and Javanese subjects 
are shown in the mean and standard deviation. 
 
 
Results 
 
 The difference in the PANSS total scores 
between the Bataknese and Javanese subjects is 
shown in Table 1.  
Table 1: Difference in the Total PANSS Score between the 
Bataknese and Javanese subjects in the sixth
 
week 
PANSS total score of Javanese subjects PANSS total score of Bataknese subjects 
50 44 
34 58 
41 62 
40 41 
57 58 
60 66 
48 62 
44 68 
54 53 
57 63 
Mean ± Standard Deviation = 48.50 ± 8.618 Mean ± Standard Deviation = 57.50 ± 8.997 
 
The characteristics of the research subjects 
can be seen in Table 2. Based on the age, the median 
(minimum-maximum) age of the Javanese subjects 
was 37.00 (26-40) years, whereas the median 
(minimum-maximum) age of the Bataknese subjects 
was 36.00 (24-40) years. Based on the education 
level, 7 Javanese subjects (33.3%) graduated middle 
school, 13 Javanese subjects (61.9%) graduated high 
school, and 1 Javanese subject (4.8%) graduated 
university. Similarly, 8 Bataknese subjects (38.1%) 
graduated middle school, 12 Bataknese subjects 
(57.1%) graduated high school, and 1 Bataknese 
subject (4.8%) graduated university. Regarding the 
employment status, 37 subjects (88.09%) were 
unemployed, and 5 subjects (11.91%) were employed 
from both groups. In the Javanese ethnic group, 1 
subject (4.8%) was employed, and 20 subjects 
(95.2%) were unemployed. Similarly, in the Bataknese 
ethnic group, 4 subjects (19%) were employed, and 
17 subjects (81%) were unemployed. The median 
(minimum-maximum) duration of illness of the 
Javanese subjects was 4.00 (1-5) years whereas the 
median duration of illness of the Bataknese subjects 
was 3.00 (1-5) years. Regarding the marital status, 
there were 9 married subjects (42.9%) and 12 
unmarried subjects (57.1%) in the Bataknese ethnic 
group whereas there were 5 married subjects (23.8%) 
and 16 unmarried subjects (76.2%) in the Javanese 
ethnic group. The mean body mass index of the 
Javanese subjects was 22.50 ± 1.30 Kg/m
2
 while the 
mean body mass index of the Bataknese subjects was 
21.64 ± 1.57 Kg/m
2
.  
The median (minimum-maximum) onset of an 
attack of the Javanese and Bataknese subjects was 
33.00 (24-35) years and 33.00 (23-35) years, 
respectively. Based on the frequency of attack, 21 
Javanese subjects (100%) experienced attacks two 
times or less. Similarly, 18 Bataknese subjects 
(85.71%) experienced attacks two times or less, and 3 
Bataknese subjects (14.29%) experienced attacks two 
to five times. In terms of insight, 2 Javanese subjects 
(9.52%) had insight I and 19 Javanese subjects 
(90.48%) had insight II whereas Bataknese subjects 
(52.38%) had insight I and 10 Bataknese subjects 
(47.62%) had insight II. Regarding the socioeconomic 
level, 11 subjects (80.95%) Javanese subjects were in 
the lower class, and 4 Javanese subjects (14.51%) 
were in the middle class while 16 Bataknese subjects 
(76.19%) were in the lower class, and 5 Bataknese 
subjects (23.81%) were in the middle class. The mean 
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PANSS total scores of the Javanese and Bataknese 
ethnic groups in the first week receiving a fixed dose 
of 6 mg of risperidone were 99.10 ± 9.88 and 104.19 ± 
12.38, respectively.  
Table 2: Distribution of Samples Based on Demographic 
Characteristics 
 
 
 
 
 
Javanese Men with 
Schizophrenia 
N (%) 
Bataknese Men with 
Schizophrenia 
N (%) 
 
 
 
p 
Age 
{Median (Minimum-Maximum)} 
 
Education Level 
Middle school 
High school 
University 
 
Employment Status 
Employed 
Unemployed 
 
37.00(26-40) 
 
 
 
7 (33.3%) 
13 (61.9%) 
1 (4.8%) 
 
 
1 (4.8%) 
20 (95.2%) 
 
36.00(24-40) 
 
 
 
8 (38.1%) 
12 (57.1%) 
1 (4.8%) 
 
 
4 (19.0%) 
17 (81.0%) 
0.559b 
 
 
 
0.747c 
 
 
 
 
0.343d 
 
Marital Status 
Married 
Not married 
 
Duration of Illness 
{Median (Minimum-Maximum)} 
Body Mass Index in the first week 
receiving risperidone with a fixed 
dose of 6 mg (Mean ± SD) 
 
 
5 (23.8%) 
16 (76.2%) 
 
4,00(1-5) 
 
22.50±1.30 
 
9 (42.9%) 
12 (57.1%) 
 
3,00(1-5) 
 
21.64±1.57 
 
0.190c 
 
 
0,078b 
 
0.061a 
 
Onset of Illness 
{Median(Minimum-Maximum)} 
 
33.00(24-35) 
 
33.00(23-35) 0.759b 
Frequency of Illness 
≤2 times of Illness 
3-5 times of Illness  
>5 times of Illness  
 
21 (100%) 
- 
- 
 
18 (85,71%) 
3 (14,29%) 
- 
 
0,232d 
Socioeconomic Level 
Lower class 
Middle class 
High class 
 
17 (80.95%) 
4 (14.51%) 
- 
 
16 (76.19%) 
5 (23.81%) 
- 
 
1.000d 
Insight 
Insight I 
Insight II 
 
2 (9.5%) 
19 (90.5%) 
 
11 (52.4%) 
10 (47.6%) 
 
 
0.003c 
PANSS Total Score in the first 
week receiving risperidone with a 
fixed dose of 6 mg 
99.10 ± 9.88 104.19 ± 12.38 0.148a 
a
Independent T-Test; 
b
Mann-Whitney U; 
c
Chi Square Test with Yates correction; 
d
Fisher 
Test. 
 
As seen in Table 3, the mean PANSS total 
score in the Javanese subjects was 42.43 ± 9.05, 
whereas the mean PANSS total score in the 
Bataknese subjects was 49.76 ± 12.65. Based on the 
study results, there was a difference in the PANSS 
total scores of men with schizophrenia between the 
Bataknese and Javanese ethnic groups who had 
received 6 mg of risperidone treatment for 6 weeks (p 
= 0.037). 
Table 3: The PANSS Total Score of Men with Schizophrenia 
from Bataknese and Javanese Ethnic Groups 
 Javanese Men with 
Schizophrenia (n = 
21) 
Bataknese Men with 
Schizophrenia 
(n = 21) 
P 
PANSS total score in the 
sixth week after receiving 
6 mg of risperidone 
(mean ± SD) 
42.43 ± 9.05 49.76 ± 12.65 0.037* 
*Independent T-Test. 
 
 
Discussion 
 
In this study, the median (minimum-
maximum) onset of the attack of the Javanese and 
Bataknese subjects was 33.00 (24-35) and 33.00 (23-
35) years, respectively. This is consistent with the 
statement of the American Psychiatric Association 
that the psychotic picture of schizophrenia usually 
appears between the late teens and middle thirties; 
the onset before adolescence is rare. The peak age 
during onset for the first psychotic episode was in the 
early to middle twenties for men and in the late 
twenties for women. The onset may be sudden or 
dangerous, but most individuals show a slow and 
gradual development of various clinically significant 
signs and symptoms. In a cohort study conducted in 
Melbourne by Gogtay in subjects at high risk for 
schizophrenia, the average age of onset was 19 ± 3.5 
years and occurred in 58% of men. In the Buoli study, 
it was stated that the mean onset age of 
schizophrenia was 23.22 ± 5.97 years [20], [21]. 
Based on the education level of the Javanese 
subjects, 7 subjects (33.3%) graduated middle school, 
13 subjects (61.9%) graduated high school, and 1 
subject (4.8%) graduated university. Similarly, the 
education level in the Bataknese subjects showed that 
8 subjects (38.1%) graduated middle school, 12 
subjects (57.1%) graduated high school, and 1 subject 
(4.8%) graduated university. Most of the subjects for 
both ethnic groups in this study were at the high 
school level. This is consistent with the findings of the 
Arnold study. Similarly, Huang found that most of the 
schizophrenic patients were in the high school level 
with 39.5% (n = 43) while 34.7% (n = 38) was in the 
university level and 25.7% (n = 28) was in the middle 
school level [22], [23]. 
In this study, the median (minimum-
maximum) duration of illness of the Javanese and 
Bataknese subjects was 4.00 (1-5) years and 3.00 (1-
5) years, respectively. The mean body mass index of 
the Javanese subjects was 22.50 ± 1.30 Kg/m
2, 
while 
the mean body mass index of the Bataknese subjects 
was 21.64 ± 1.57 Kg/m
2
. Regarding the employment 
status, 1 Javanese subject (4.8%) was employed and 
20 Javanese subjects (95.2%) were unemployed 
whereas 4 Bataknese subjects (19%) were employed 
and 17 Bataknese subjects (81%) were unemployed. 
This is by the literature [22]. Furthermore, a study by 
Huang and colleagues showed that there were 46 
unemployed schizophrenic patients (42.2%) and 37 
employed schizophrenic patients (33.9%) [22]. 
Based on the marital status, 9 subjects 
(42.9%) were married, and 12 subjects (57.1%) were 
not married in the Bataknese ethnic group whereas 5 
subjects (23.8%) were married, and 16 subjects 
(76.2%) were not married in the Javanese ethnic 
group. This is also by the findings of Arnold and 
colleagues regarding patients who received 
antipsychotics [23]. Similarly, Huang and colleagues 
in China reported that 61 schizophrenic patients 
(56%) were not married, and 23 schizophrenic 
patients were married (21.1%) [22]. 
Regarding the socioeconomic level, 17 
Javanese subjects (80.95%) were in the lower class, 
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and 4 Javanese subjects (14.51%) were in the middle 
class while 16 Bataknese subjects (76.19%) were in 
the lower class, and 5 Bataknese subjects (23.81%) 
were in the middle class. Huang and colleagues in 
China found that 29 subjects (26.6%) were in the 
lower class, 62 subjects (56.9%) were in the middle 
class, and 18 subjects (16.5%) were in the high class 
among schizophrenic patients [22]. The present study 
also found that the mean PANSS total score of 
Javanese subjects was 42.43 ± 9.05 while the mean 
PANSS total score of Bataknese subjects was 49.76 ± 
12.65. Thus, there was a significant difference in the 
PANSS total score of men with schizophrenia 
receiving 6 mg of risperidone for 6 weeks between the 
Javanese and Bataknese ethnic groups (p = 0.037). 
This is consistent with a pilot study conducted by 
Frackiewicz and colleagues in the United States which 
found that there was a significant difference in the 
PANSS score between 10 Hispanic schizophrenic in-
patients and 8 non-Hispanic schizophrenic in-patients 
who received risperidone (p < 0.02) [7]. 
One of the limitations in the current study was 
that this study did not examine the Bataknese 
ethnicity more specifically because this ethnicity 
consists of five sub-ethnicities. In addition, the study 
also did not explore the cause of the difference in the 
PANSS total scores between the Javanese and 
Bataknese subjects in the sixth week after receiving a 
fixed dose of 6 mg of risperidone, whether it was due 
to biological factors such as genetic influencing drug 
pharmacokinetics and pharmacodynamics, 
environmental factors, or cultural factors. The subjects 
in this study did not have the same belief because 
belief is a cultural factor that might influence the 
effectiveness or adherence to drug therapy [19]. 
In conclusion, the mean PANSS total score of 
the Javanese men with schizophrenia was 42.43 ± 
9.05 while the mean PANSS total score of the 
Bataknese men with schizophrenia was 49.76 ± 
12.65. Thus, there was a difference in the PANSS 
total score between Bataknese and Javanese men 
with schizophrenia in which Javanese patients were 
more responsive to the 6 mg of risperidone treatment 
for 6 weeks (p = 0.037), so the research hypothesis 
was accepted. 
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